Hans-Joachim Carius - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Hans-Joachim Carius

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

The American Naturalist|November 13, 2004

The evolution of virulence when parasites cause host castration and gigantismDieter Ebert, Hans Joachim Carius, Tom Little, et al.

Advances in Therapy|November 23, 2017

Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in AustraliaAdrian Skelly, Hans-Joachim Carius, Vladimir Bezlyak, et al.

International Journal of Clinical Pharmacology and Therapeutics|September 1, 2018

Basic characteristics and representativeness of the German Disease Analyzer database Wolfgang Rathmann, Brenda Bongaerts, Hans-Joachim Carius, et al.

Advances in Therapy|February 2, 2017

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United KingdomRobert L Johnston, Hans-Joachim Carius, Adrian Skelly, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

The American Naturalist|November 13, 2004

The evolution of virulence when parasites cause host castration and gigantismDieter Ebert, Hans Joachim Carius, Tom Little, et al.

Advances in Therapy|November 23, 2017

Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in AustraliaAdrian Skelly, Hans-Joachim Carius, Vladimir Bezlyak, et al.

International Journal of Clinical Pharmacology and Therapeutics|September 1, 2018

Basic characteristics and representativeness of the German Disease Analyzer database Wolfgang Rathmann, Brenda Bongaerts, Hans-Joachim Carius, et al.

Advances in Therapy|February 2, 2017

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United KingdomRobert L Johnston, Hans-Joachim Carius, Adrian Skelly, et al.

Pageof 1